rs137852210
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000298542.9(FRMD7):c.70G>A(p.Gly24Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000000923 in 1,083,436 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G24E) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000298542.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRMD7 | NM_194277.3 | c.70G>A | p.Gly24Arg | missense_variant | 2/12 | ENST00000298542.9 | NP_919253.1 | |
FRMD7 | NM_001306193.2 | c.70G>A | p.Gly24Arg | missense_variant | 2/12 | NP_001293122.1 | ||
FRMD7 | XM_017029947.3 | c.22G>A | p.Gly8Arg | missense_variant | 2/12 | XP_016885436.1 | ||
FRMD7 | XM_017029948.3 | c.30-6565G>A | intron_variant | XP_016885437.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRMD7 | ENST00000298542.9 | c.70G>A | p.Gly24Arg | missense_variant | 2/12 | 1 | NM_194277.3 | ENSP00000298542 | P1 | |
FRMD7 | ENST00000464296.1 | c.70G>A | p.Gly24Arg | missense_variant | 2/12 | 1 | ENSP00000417996 | |||
FRMD7 | ENST00000687717.1 | n.328G>A | non_coding_transcript_exon_variant | 2/3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 9.23e-7 AC: 1AN: 1083436Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 349544
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Nystagmus 1, congenital, X-linked Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2011 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Jul 17, 2023 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with congenital nystagmus 1, and infantile periodic alternating nystagmus (MIM#310700). Dominant negative is also a suggested mechanism (PMID: 23406872). (I) 0109 - This gene is associated with X-linked recessive disease. However, heterozygous females may have symptoms (OMIM, PMID: 19072571). (I) 0200 - Variant is predicted to result in a missense amino acid change from glycine to arginine. (I) 0253 - This variant is hemizygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated FERM N-terminal domain (DECIPHER). (I) 0704 - Another missense variant comparable to the one identified in this case has limited previous evidence for pathogenicity. This alternative change (p.(Gly24Trp)) has been reported in a hemizygous individual with congenital nystagmus (PMID: 35705619). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported as pathogenic, and described in at least five individuals with nystagmus, or congenital motor nystagmus (ClinVar, PMID: 17013395, PMID: 21303855, PMID: 25678693, PMID: 35705619, PMID: 17768376). (SP) 1205 - This variant has been shown to be maternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2022 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 10786). This missense change has been observed in individual(s) with X-linked infantile nystagmus (PMID: 17013395, 17768376, 25678693, 30942644). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 24 of the FRMD7 protein (p.Gly24Arg). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at